Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test
Pediatric Allergy and Immunology · 2026
DOI: 10.1111/pai.70300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2026. Verfasst von Ana Esteve-Sole und 18 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Flow Cytometry, Leukocytes, Mononuclear. Die Arbeit nennt 32 Literaturangaben. Gefördert von: NIH/NIAID, Intramural Research Program NIAID, ISCIII and EU FIS-PI21/01642.
Abstract (Originalsprache)
Background
Heterozygous STAT3 variants acting by dominant negative (DN), gain‐of‐function (GOF), or haploinsufficiency (HI) mechanisms that have been associated with different inborn errors of immunity. However, the biological impact of STAT3 variants is complex to determine and it generally involves vector‐generation, transfection, and multiple iterations for definition.
Objective
To establish a single, reliable test to functionally characterize putative disease‐causing STAT3 variants in patient primary cells.
Methods
We recruited patients carrying previously published/validated STAT3‐DN ( n = 13), STAT3‐GOF ( n = 4), and STAT3‐HI ( n = 5) variants. We functionally evaluated the IL‐10‐mediated/STAT3‐dependent inhibition ratio of LPS‐induced TNF‐α production by peripheral blood mononuclear cells (PBMC) using flow cytometry to evaluate the biologic impact of STAT3 variants. Optimization and threshold definition were performed by bootstrapping and k‐fold cross‐validation of Receiver Operating Characteristic (ROC)–area under the curve (AUC).
Results
The inhibition ratio of TNF‐α production was significantly diminished in STAT3‐DN (−3.44‐fold, p < .0001) and STAT3‐HI samples (−2.28‐fold, p < .0001), while significantly augmented in STAT3‐GOF samples (+1.47‐fold, p = .002) when compared to healthy controls (HC, n = 16). Optimizing the combinations of IL‐10 concentrations discriminated between HC and STAT3‐DN (ROC‐AUC = 1), and STAT3‐GOF (ROC‐AUC = 0.89). Further test optimization allowed discrimination between STAT3‐HI variants when compared to HC (ROC‐AUC = 1) and to STAT3‐DN (ROC‐AUC = 0.92).
Conclusion
Determination of the IL‐10 mediated, STAT3‐dependent TNFα inhibition ratio in PBMC‐derived monocytes by flow cytometry is a sensitive and specific method to functionally assess and discriminate STAT3‐DN, ‐GOF, and ‐HI variants. This test can be used in research and clinical laboratory settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, Bethesda, Maryland, USA.
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, Texas, USA.
- Department of Pediatrics, Division of Rheumatology/Immunology, Washington University in St. Louis, St. Louis, Missouri, USA.
- Immunology Service, National Pediatric Hospital J.P. Garrahan, Buenos Aires, Argentina.
- Immunodeficiencies Unit, Hospital 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), School of Medicine, Complutense University, Madrid, Spain.
ORCID-Profile: Taura Webb, Carolina Bouso, Sergio D Rosenzweig
Förderung
- NIH/NIAID
- Intramural Research Program NIAID
- ISCIII and EU FIS-PI21/01642
- CDI Washington University
- Intramural Research Program NIH Clinical Center
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Esteve-Sole, A., Freeman, A. F., Hsu, A., Vogel, T. P., Satter, L. F., Bergerson, J. R. E., Webb, T., Pechacek, J., McDaniels, K., Cooper, M. A., Bouso, C., Oleastro, M., Danielian, S., Gonzalez-Granados, L. I., Lionakis, M. S., Holland, S. M., Fleisher, T. A., Kuehn, H. S., & Rosenzweig, S. D. (2026). Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70300
Vancouver
Esteve-Sole A, Freeman AF, Hsu A, Vogel TP, Satter LF, Bergerson JRE, et al. Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test. Pediatric Allergy and Immunology. 2026. doi:10.1111/pai.70300
BibTeX
@article{EsteveSole2026,
author = {Esteve-Sole, Ana and Freeman, Alexandra F and Hsu, Amy and Vogel, Tiphanie P and Satter, Lisa Forbes and Bergerson, Jenna R E and Webb, Taura and Pechacek, Joseph and McDaniels, Kristen and Cooper, Megan A and Bouso, Carolina and Oleastro, Matias and Danielian, Silvia and Gonzalez-Granados, Luis Ignacio and Lionakis, Michail S and Holland, Steven M and Fleisher, Thomas A and Kuehn, Hye Sun and Rosenzweig, Sergio D},
title = {Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test},
journal = {Pediatric Allergy and Immunology},
year = {2026},
doi = {10.1111/pai.70300}
}
EUVIMED